Eli Lilly and Company News - April 28, 2026

Eli Lilly signs $2.25 billion Profluent deal, targeting AI gene editing

Eli Lilly partnered with Profluent on April 28, 2026, to develop AI-driven genetic medicines. The collaboration carries a potential total value of $2.25...